United States · FDA National Drug Code directory
Triamterene and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8700_a0813a88-794a-4dbe-a367-629f941e2bbc
- Product NDC
- 68788-8700
- Form
- CAPSULE
- Composition / generic term
- Triamterene and Hydrochlorothiazide
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240617
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAMTERENE — 37.5 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BLISTER PACK (68788-8700-1) · 68788-8700-1
- 30 CAPSULE in 1 BOTTLE (68788-8700-3) · 68788-8700-3
- 60 CAPSULE in 1 BOTTLE (68788-8700-6) · 68788-8700-6
- 90 CAPSULE in 1 BOTTLE (68788-8700-9) · 68788-8700-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →